Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis
Clinical trial NCT05384249 · TERMINATED
Trial details
- NCT number
- NCT05384249
- Sponsor
- ACELYRIN Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2025-02-07
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.